Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184644
Max Phase: Preclinical
Molecular Formula: C10H28FN6O13P3
Molecular Weight: 484.16
Associated Items:
ID: ALA5184644
Max Phase: Preclinical
Molecular Formula: C10H28FN6O13P3
Molecular Weight: 484.16
Associated Items:
Canonical SMILES: Cc1cn([C@H]2C[C@H](F)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O.N.N.N.N
Standard InChI: InChI=1S/C10H16FN2O13P3.4H3N/c1-5-3-13(10(15)12-9(5)14)8-2-6(11)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18;;;;/h3,6-8H,2,4H2,1H3,(H,19,20)(H,21,22)(H,12,14,15)(H2,16,17,18);4*1H3/t6-,7+,8+;;;;/m0..../s1
Standard InChI Key: DFERSTZGBUFRJT-ZKRIHRHSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 484.16 | Molecular Weight (Monoisotopic): 483.9849 | AlogP: -0.19 | #Rotatable Bonds: 8 |
Polar Surface Area: 223.91 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 15 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 0.90 | CX Basic pKa: | CX LogP: -1.20 | CX LogD: -8.61 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.30 | Np Likeness Score: 0.86 |
1. Weising S, Weber S, Schols D, Meier C.. (2022) Triphosphate Prodrugs of the Anti-HIV-Active Compound 3'-Deoxy-3'-fluorothymidine (FLT)., 65 (18.0): [PMID:36099330] [10.1021/acs.jmedchem.2c00665] |
Source(1):